erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
BURDIN JC et al. [Comparative study of the antistaphylococcal bacteriostatic activity of 4 antibiotics: erythromycin, spiramycin, oleandomycin and novobiocin]. 1959 Rev Med Nancy pmid:13806021
ANDERSON RC et al. Pharmacology and toxicology of propionyl erythromycin ester lauryl sulfate. 1959 J Am Pharm Assoc Am Pharm Assoc pmid:13848813
STEPHENS VC et al. Esters of erythromycin. IV. Alkyl sulfate salts. 1959 J Am Pharm Assoc Am Pharm Assoc pmid:13854943
SHIMOHIRA M [Mode of action of the antagonism and additive effects caused by the combination of erythromycin and other antibacterial substances. I. On the in vitro combination of penicillin and erythromycin, especially in the matter of the antagonism phenomenon]. 1959 Jpn. J. Microbiol. pmid:13856354
VIALLIER J et al. [Comparative study of the blood level of active erythromycin obtained in the human organism by administration of base or of propionate]. 1959 C. R. Seances Soc. Biol. Fil. pmid:13842057
VON WANDRUSZKA R [Local treatment of male adnexitis with antibiotics, especially erythromycin]. 1959 Medizinische pmid:13643478
MONTGOMERY CH and KNOX JM Erythromycin in the treatment of early syphilis; a preliminary report. 1959 AMA Arch Derm pmid:13669748
NEW AND Nonofficial Drugs: erythromycin propionate. 1959 J Am Med Assoc pmid:13672809
CLUZEL R et al. [Combination erythromycin-oleandomycin: favorable bactericidal effect on pathogenic staphylococci]. 1959 Sem Hop pmid:13624776
HIRSCH HA et al. Antibacterial activity of serum of normal men after oral doses of erythromycin propionate and triacetyloleandomycin. 1959 N. Engl. J. Med. pmid:13632901
TIDWELL RA and LEWIS D Erythromycin prophylaxis: a four year study. 1959 Antibiotic Med Clin Ther (New York) pmid:13661855
HALLETT WY et al. Chemoprophylaxis in chronic obstructive pulmonary emphysema: a twelve-week study with erythromycin. 1959 Am. Rev. Respir. Dis. pmid:14399110
DUPERRAT and PRINGUET [Dramatic Herxheimer phenomenon in the course of treatment of severe furunculosis by indicated antibiotics]. 1959 Jan 9-16 Bull Mem Soc Med Hop Paris pmid:13629325
ISKRZHITSKAIA AI and BLIUMENTAL' KV [Use of antibiotics of the tetracycline series and of erythromycin in experimental]. 1959 Jul-Aug Antibiotiki pmid:13848469
TEBIAKINA AE and SEMENOV SM [Determination of biological activity of erythromycin in all stages of its production]. 1959 Jul-Aug Antibiotiki pmid:13837248
LIMSON BM and ARAGON PR Current status of erythromycin. Laboratory and clinical studies on propionyl erythromycin. 1959 Jul-Sep Acta Med Philipp pmid:13762201
ALBORNOZ PLATA A [Erythromycin-carbarsone in the treatment of amebiasis]. 1959 Oct-Dec Rev Fac Med Univ Nac Colomb pmid:13792418
CALESNICK B Effectiveness of oral erythromycin propionate in commonly occurring infections. 1959-1960 Antibiot Annu pmid:13806941
MARMELL M et al. Clinical trial of erythromycin propionate for acute anterior gonococcal urethritis. 1959-1960 Antibiot Annu pmid:14421354
REICHELDERFER TE et al. Clinical studies of propionyl erythromycin lauryl sulfate in children. 1959-1960 Antibiot Annu pmid:14437052
SALITSKY S et al. Erythromycin propionate: a clinical and laboratory study. 1959-1960 Antibiot Annu pmid:14441020
PRASAD AS Severe urticaria following erythromycin therapy. 1960 Acta Med Iran pmid:14488491
WEISS E and DRESSLER HR Selection of an erythromycin-resistant strain of Rickettsia prowazekii. 1960 Am J Hyg pmid:13843711
HAMILTON WJ and MARTIN RJ Significance of zones of inhibition produced by penicillin and erythromycin on the genus Proteus. 1960 J Med Lab Technol pmid:13711025
HENNEQUET A and MELEKIAN B [100 patients treated with erythromycin propionate]. 1960 Rev Prat pmid:13713358
HERRELL WE et al. Erythrocillin: a new approach to the problem of antibiotic-resistant staphylococci. 1960 Antibiotic Med Clin Ther (New York) pmid:13713711
BIEGELEISEN JZ and MOODY MD Sensitivity in vitro of eighteen strains of Pasteurelia tularensis to erythromycin. 1960 J. Bacteriol. pmid:13800534
CORCORAN JW et al. Actinomycete antibiotics. I. The biological incorporation of propionate into the macrocyclic lactone of erythromycin. 1960 J. Biol. Chem. pmid:13811922
CRONK GA and NAUMANN DE The treatment of infections with erythromycin propionate. 1960 Antibiotic Med Clin Ther (New York) pmid:13812968
DELTA BG and SCOTT RB Erythromycin propionate ointment in the treatment of cutaneous bacterial infections in children. 1960 Antibiotic Med Clin Ther (New York) pmid:13815757
CAIRELLA M [On the subject of antibiotic therapy. II]. 1960 Clin Ter pmid:13689841
CATANIA E [Erythromycin and intestinal occlusions. Preliminary note]. 1960 Boll. Soc. Ital. Biol. Sper. pmid:13691528
ERIKSEN KR et al. [Erythromycin-resistant Staphylococci. Incidence and mode of development]. 1960 Ugeskr. Laeg. pmid:13697146
RZEWNIS K et al. [Studies on the synergistic activity of tetracycline and erythromycin. I. Studies in vitro]. 1960 Med Dosw Mikrobiol pmid:13745102
LIMSON BM and ARAGON PR Clinical and in vitro efficacy of propionyl erythromycin ester. 1960 Antibiotic Med Clin Ther (New York) pmid:13762200
GRIFFITH RS Comparison of antibacterial activity in the sera of subjects ingesting propionyl erythromycin lauryl sulfate and erythromycin ethyl carbonate. 1960 Antibiotic Med Clin Ther (New York) pmid:13851768
VEIS RA and EDEL'SHTEIN SI [Erythromycin (erythrocin, ilotycin)]. 1960 Ter. Arkh. pmid:13780602
GERNAND K and HAEHNEL H [Auto vaccine therapy in chronic recurrent infections]. 1960 Dtsch Gesundheitsw pmid:13827552
SUSZKO K et al. [Sensitivity of Staphylococcus aureus to erythromycin with special reference to co-existing sensitivity to penicillin, streptomycin, aureomycin and chloramphenicol]. 1960 Pr Kom Med Dosw pmid:13835811
TATE LS Antibiotic combination. In vivo and in vitro evaluation of oleandomycin, erythromycin and tetracycline on cultures of staphylococcus aureus. 1960 Chemotherapia (Basel) pmid:13837036
THIERS H et al. [Therapeutic trials of a new ester of erythromycin, the propionate, in infected dermatoses in childhood]. 1960 Lyon Med pmid:13837827
DOBRZANSKI WT and PULAWSKA E [Studies on the role of mutation in erythromycin resistance in strains of staphylococci belonging to various phage groups]. 1960 Med Dosw Mikrobiol pmid:13723289
DOONER H et al. [Treatment of staphylococcal infections with erythromycin propionate]. 1960 Rev Med Chil pmid:13723831
SALDANA TATE L In vivo and in vitro evaluation of oleandomycin, erythromycin, and tetracycline against cultures of Staphylococcus aureus. 1960 Antibiot Chemother (Northfield) pmid:14440930
SCHNEIERSON SS et al. Inhibition of Pseudomonas aeruginosa pigment formation by chloramphenicol and erythromycin. 1960 Antibiot Chemother (Northfield) pmid:14443279
SETTEL E Evaluation of erythromycin propionate (ilosone) in general practice. 1960 Antibiotic Med Clin Ther (New York) pmid:14445202
SHUBIN H et al. Clinical studies of propionyl erythromycin in infections. 1960 Antibiotic Med Clin Ther (New York) pmid:14446275
HALL GA et al. Erythromycin stearate and propionyl erythromycin: a comparison of blood levels obtained after oral administration. 1960 Antibiotic Med Clin Ther (New York) pmid:14399035
HIRSCH HA et al. Effect of food on absorption of a new form of erythromycin propionate. 1960 Am. J. Med. Sci. pmid:14401969
ISENBERG HD et al. A clinical and laboratory evaluation of propionyl erythromycin. 1960 Antibiotic Med Clin Ther (New York) pmid:14405887